| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 11 | |
| #2 | Australia | 8 | |
| #3 | EPO (European Patent Office) | 6 | |
| #4 | United States | 6 | |
| #5 | Brazil | 5 | |
| #6 | Hong Kong | 5 | |
| #7 | Singapore | 5 | |
| #8 | African Regional Industrial Property Organization | 4 | |
| #9 | Costa Rica | 4 | |
| #10 | Israel | 4 | |
| #11 | Japan | 4 | |
| #12 | Republic of Korea | 4 | |
| #13 | Mexico | 4 | |
| #14 | Nicaragua | 4 | |
| #15 | WIPO (World Intellectual Property Organization) | 4 | |
| #16 | South Africa | 4 | |
| #17 | Canada | 3 | |
| #18 | Chile | 3 | |
| #19 | China | 3 | |
| #20 | Colombia | 3 | |
| #21 | Ecuador | 3 | |
| #22 | Malaysia | 3 | |
| #23 | New Zealand | 3 | |
| #24 | EAPO (Eurasian Patent Organization) | 1 | |
| #25 | Georgia | 1 | |
| #26 | India | 1 | |
| #27 | Republic of Moldova | 1 | |
| #28 | Philippines | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Enzymes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Henry William | 78 |
| #2 | Wolf-Garraway Richard | 30 |
| #3 | Mayo John Charles | 26 |
| #4 | Earl Michael James | 23 |
| #5 | William Henry | 16 |
| #6 | Mayo John | 11 |
| #7 | Richard Wolf-Garraway | 6 |
| #8 | Wolf Garraway Richard | 5 |
| #9 | John Charles Mayo | 4 |
| #10 | Michael James Earl | 4 |
| Publication | Filing date | Title |
|---|---|---|
| GB201905796D0 | Modified liposomes for use in the treatment of haemophilia | |
| GB201813531D0 | Modified liposomes for use in the treatment of haemophilia | |
| GB201518172D0 | Colloidal particles for use in medicine | |
| GB201518171D0 | Colloidal particles for topical administration with therapeutic agent | |
| GB201518170D0 | Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent | |
| GB201417589D0 | Pharmaceutical Formulations | |
| BR112014025737A2 | method for administering a therapeutic agent, method for preventing entry of a therapeutic agent, method for modulating the rate of release of a therapeutic agent, therapeutic agent, dosage forms, method of treating a disease and parts kit |